To study the effect of â??Arq-i-ZiÌ?ra in control of obesity

Evaluation of the Efficacy of â??Arq-i-ZiÌ?ra in Controlling the progress of Siman MufritÌ£: A Clinical Trial - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/054925

Enrollment

Registered

2023-07-07

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

Intervention1: â??Arq-i-ZiÌ?ra: â??Arq-i-ZiÌ?ra contains Ajwain desi(Carum copticum)-250gms Zanjabeel(Zingiber officinale)-125gms ZiÌ?ra safed (Cuminum cyminum linn)-375 gms ZiÌ?ra siyah (Carum car

Eligibility

Inclusion criteria

Inclusion criteria: Patients with BMI >30kg/m2

Exclusion criteria

Exclusion criteria: Unstable, bedridden, mentally retarded and with serious illness patients Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Change in Body weight Change in Waist hip ratio Change in Basal Metabolic rateTimepoint: baseline,15th day,30th day,45th day and 60th day.	—

Secondary

Measure	Time frame
change in skinfold thicknessTimepoint: baseline & 60th day	—

Countries

India

Contacts

Public ContactProf Abdul Haseeb Ansari

National Institute of Unani Medicine

ahansari001@gmail.com9448258140

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026